0
contact-banner

Regadenoson

Regadenoson

API0232782

Regadenoson

Rasagiline Mesylate is an antiparkinsonian drug.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    313348-27-5

  • Synonyms

    Regadenoson; 313348-27-5; CVT-3146

  • CHEMBL ID

    CHEMBL317052

  • Indications

  • Molecule Type

    Small molecule

  • Compound CID

    219024

  • Molecular Weight (g/mol)

    390.35

  • Molecular Formula

    C15H18N8O5

  • InChI

    InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1

  • InChIKey

    LZPZPHGJDAGEJZ-AKAIJSEGSA-N

  • SMILES

    CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N

  • IUPAC Name

    1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide

  • Exact Mass (Da)

    390.1400157

  • Monoisotopic Mass (Da)

    390.1400157

OUR PRODUCTS